Stockreport

Amgen begins late-stage trials for obesity therapy [Seeking Alpha]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF Amgen ( NASDAQ: AMGN ) has announced the beginning of two Phase 3 studies for its weight loss candidate MariTide as the company aims to take a slice of a burgeoning obes [Read more]